Vident Advisory’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$772K Buy
16,336
+3,477
+27% +$179K 0.01% 1123
2026
Q1
$762K Sell
12,859
-979
-7% -$63.5K 0.01% 1004
2025
Q4
$854K Sell
13,838
-140
-1% -$8.57K 0.01% 885
2025
Q3
$872K Buy
13,978
+9,119
+188% +$635K 0.01% 892
2025
Q2
$388K Buy
4,859
+623
+15% +$52.1K ﹤0.01% 1189
2025
Q1
$364K Sell
4,236
-7,018
-62% -$576K 0.01% 1190
2024
Q4
$879K Buy
11,254
+305
+3% +$23.7K 0.02% 689
2024
Q3
$789K Sell
10,949
-747
-6% -$52.9K 0.02% 720
2024
Q2
$805K Buy
11,696
+8,875
+315% +$601K 0.02% 674
2024
Q1
$205K Buy
+2,821
New +$189K ﹤0.01% 1205

Other funds holding PBH

Vident Advisory's PBH Position: Q2 2026 in Review

Vident Advisory increased its Prestige Consumer Healthcare (PBH) stake by 27% in Q2 2026, buying an estimated $179K and bringing the position to 16,336 shares worth $772K. The position accounts for 0.01% of the portfolio, ranked #1123.

Vident Advisory first reported a position in PBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $879K in Q4 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Vident Advisory held 16,336 shares of Prestige Consumer Healthcare worth $772K as of Q2 2026.
  • Vident Advisory bought 3,477 Prestige Consumer Healthcare shares in Q2 2026, an estimated $179K.
  • Prestige Consumer Healthcare made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1123 holding.
  • Vident Advisory first reported a position in Prestige Consumer Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Vident Advisory's Prestige Consumer Healthcare position peaked at $879K in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.